Acadian Asset Management’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-918
| Closed | -$93K | – | 1879 |
|
|
2023
Q1 | $93K | Buy |
918
+258
| +39% | +$26.1K | ﹤0.01% | 1407 |
|
|
2022
Q4 | $92K | Buy |
+660
| New | +$92K | ﹤0.01% | 1454 |
|
|
2022
Q3 | – | Sell |
-31
| Closed | -$27K | – | 1812 |
|
|
2022
Q2 | $27K | Buy |
31
+14
| +82% | +$12.2K | ﹤0.01% | 1584 |
|
|
2022
Q1 | $42K | Buy |
17
+9
| +113% | +$22.2K | ﹤0.01% | 1489 |
|
|
2021
Q4 | $19K | Buy |
+8
| New | +$19K | ﹤0.01% | 1616 |
|